Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.80% | 8.31% | -28.01% | 34.19% | -100.43% |
| Total Depreciation and Amortization | 27.27% | 22.22% | 80.00% | 66.67% | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.82% | 2.92% | 30.02% | -77.44% | 238.73% |
| Change in Net Operating Assets | 105.15% | -241.49% | 10,908.00% | -100.98% | 13,268.42% |
| Cash from Operations | 3.66% | -44.90% | -2.21% | -91.47% | 14.57% |
| Capital Expenditure | -113.33% | 69.39% | -8.89% | -246.15% | -30.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -113.33% | 69.39% | -8.89% | -246.15% | -30.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -91.13% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 62.69% | -495.56% | -100.21% |
| Cash from Financing | 108.82% | -100.66% | 706.91% | -115.69% | -94.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.77% | -171.19% | 49.42% | -5,180.63% | -100.23% |